Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
Tue, November 28, 2023
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
Emily Bodnar Reiterated (SLRN) at Strong Buy and Held Target at $30 on, Nov 28th, 2023
Emily Bodnar of HC Wainwright & Co., Reiterated "Acelyrin, Inc." (SLRN) at Strong Buy and Held Target at $30 on, Nov 28th, 2023.
Emily has made no other calls on SLRN in the last 4 months.
There is 1 other peer that has a rating on SLRN. Out of the 1 peers that are also analyzing SLRN, all agrees with Emily's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $19 on, Wednesday, September 13th, 2023
